FDA NDC Directory · JSON-LD · Markdown

YESCARTA

NDC 71287-119 · CELLULAR THERAPY · SUSPENSION

Generic nameaxicabtagene ciloleucel
Labeler / ManufacturerKite Pharma, Inc.
Marketing categoryBiologic License Application · App BLA125643
Dosage form / routeSUSPENSION · INTRAVENOUS
Active ingredientsAXICABTAGENE CILOLEUCEL (2000000 1/68mL)
Marketing started20171018
Package count1

External sources

Source: openFDA. Public-domain (CC0).